Red X iconGreen tick iconYellow tick icon
The University of Otago has launched a new brand. Find out more

Contact Details

Email
dee.mangin@otago.ac.nz
Position
Professor
Department
Department of Primary Care and Clinical Simulation (Christchurch)
Qualifications
MBChB DPH (Otago)
Research summary
General Practice

Research

Dee Mangin is a New Zealand family physician who is currently Professor and Director of the Primary Care Research Group at the Christchurch School of Medicine, University of Otago. Her interests include the role and value of generalist primary care; innovative models of primary care delivery; rational prescribing; effective incorporation of evidence into patient centered practice; and the influences of science, policy and commerce on the nature of care.

An area of current focus is multimorbidity and polypharmacy among older adults as a lens for promoting care that maps onto patient priorities and where the burden or care does not exceed the patient’s capacity to benefit.

She has wide clinical research experience in primary care, including observational and interventional quantitative research methods and community randomized control trials (RCTs) of innovative models of care and setting up and leading practice based research networks including MUSIC (the McMaster University Sentinel and Information Collaboration).

Dee has experience leading RCTs of clinical interventions in areas such as antidepressant use, community acquired pneumonia, antibiotics in urinary tract infections, and deprescription trials.

She has received awards for leadership in Family Medicine and in Family Medicine research that include the Royal New Zealand College of General Practitioners Distinguished Service Award and the Canadian College of Family Physicians Donald I Rice Award.

Publications

Cossette, B., Griffith, L., Emond, P. D., Mangin, D., Moss, L., Boyko, J., … Dolovich, L. (2024). Drug and natural health product data collection and curation in the Canadian Longitudinal Study on Aging. Canadian Journal on Aging / La Revue canadienne du vieillissement. Advance online publication. doi: 10.1017/S0714980823000806 Journal - Research Article

Okafor, C. E., Keramat, S. A., Comans, T., Page, A. T., Potter, K., Hilmer, S. N., … Mangin, D., … Etherton-Beer, C. (2024). Cost-consequence analysis of deprescribing to optimize health outcomes for frail older people: A within-trial analysis. Journal of the American Medical Directors Association. Advance online publication. doi: 10.1016/j.jamda.2023.12.016 Journal - Research Article

Duncan, S., Bergler, H. U., Menclova, A., Pickering, J. W., Nishtala, P. S., Ailabouni, N., … Mangin, D., & Jamieson, H. (2024). The drug burden index and level of frailty as determinants of healthcare costs in a cohort of older frail adults in New Zealand [Economic evaluation]. Value in Health Regional Issues, 41, 72-79. doi: 10.1016/j.vhri.2023.11.009 Journal - Research Article

Elsedfy, Y., Mangin, D., Jamieson, H., Berger, U., Nishtala, P., Weaver, S., … Ailabouni, N. (2023). An international comparison of deprescribing interventional studies: How to determine factors that contribute to translational deprescribing success? Pharmacy Education, 23(6), (pp. 361). doi: 10.46542/pe.2023.236.350423 Conference Contribution - Published proceedings: Abstract

Mangin, D. (2023). Using pilot and feasibility RCT methods: Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Proceedings of the New Zealand Primary Health Care, General Practice & Rural Health Research Symposium. (pp. 11). Retrieved from https://www.otago.ac.nz/wellington/departments/primaryhealthcaregeneralpractice Conference Contribution - Published proceedings: Abstract

Back to top